Fig. 3From: Long-term outcomes of busulfan plus melphalan-based versus melphalan 200 mg/m2 conditioning regimens for autologous hematopoietic stem cell transplantation in patients with multiple myeloma: a systematic review and meta-analysisComparisons of best treatment response after auto-HSCT between MM patients having undergone HDMEL and BUMEL-based conditioning regimensBack to article page